These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 9064431)

  • 1. [Tissue angiotensin II and its impact in the treatment of arterial hypertension].
    Escobar-Morreale HF; González Albarrán O; García Robles R
    Med Clin (Barc); 1997 Jan; 108(3):105-8. PubMed ID: 9064431
    [No Abstract]   [Full Text] [Related]  

  • 2. Renin angiotensin system antagonists and anesthesia.
    Colson P; Ryckwaert F; Coriat P
    Anesth Analg; 1999 Nov; 89(5):1143-55. PubMed ID: 10553825
    [No Abstract]   [Full Text] [Related]  

  • 3. Drugs targeting the renin-angiotensin-aldosterone system.
    Zaman MA; Oparil S; Calhoun DA
    Nat Rev Drug Discov; 2002 Aug; 1(8):621-36. PubMed ID: 12402502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of the selective blocking of angiotensin II receptors in the treatment of cardiovascular diseases].
    Carnovali M
    Clin Ter; 2001; 152(2):103-6. PubMed ID: 11441521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic perspectives: association of ACE inhibitors and angiotensin receptor blockers].
    Costantino S; Millozzi F; Scarlata S
    Clin Ter; 2001; 152(2):77-8. PubMed ID: 11441526
    [No Abstract]   [Full Text] [Related]  

  • 6. Blockade of the renin-angiotensin-aldosterone system with combination angiotensin receptor antagonist and ACE inhibitor therapy: observations from Val-HeFT and CALM.
    Chin BS; Lip GY
    J Hum Hypertens; 2001 Feb; 15(2):89-92. PubMed ID: 11317186
    [No Abstract]   [Full Text] [Related]  

  • 7. [Alternative pathways of angiotensin I. The glimpse of new possibilities in the treatment of hypertension and heart failure].
    Francischetti EA
    Arq Bras Cardiol; 1995 Mar; 64(3):191-4. PubMed ID: 7487502
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal mechanisms of angiotensin II-induced hypertension.
    Granger JP; Schnackenberg CG
    Semin Nephrol; 2000 Sep; 20(5):417-25. PubMed ID: 11022893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The renin-angiotensin system and blood pressure regulation].
    Mann J
    Dtsch Med Wochenschr; 1994 Jul; 119(27):965-6. PubMed ID: 8026312
    [No Abstract]   [Full Text] [Related]  

  • 10. [The clinical pharmacology of angiotensin II antagonists].
    Arabidze GG; Novikova LS
    Farmakol Toksikol; 1990; 53(2):80-6. PubMed ID: 2369961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Historical perspective of renin-angiotensin system blocking in the treatment of arterial hypertension].
    Coca A; Redón J
    Med Clin (Barc); 1996 Mar; 106(12):457-9. PubMed ID: 8656731
    [No Abstract]   [Full Text] [Related]  

  • 12. Targeting the renin-angiotensin system for the reduction of cardiovascular outcomes in hypertension: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Kjeldsen SE; Lyle PA; Tershakovec AM; Devereux RB; Oparil S; Dahlöf B; de Faire U; Fyhrquist F; Ibsen H; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Wedel H
    Expert Opin Emerg Drugs; 2005 Nov; 10(4):729-45. PubMed ID: 16262560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Renin-angiotensin system blocking drugs in the diagnosis and treatment of arterial hypertension].
    Kabat M; Makowiecka-Cieśla M
    Kardiol Pol; 1984; 27(2):147-57. PubMed ID: 6328092
    [No Abstract]   [Full Text] [Related]  

  • 14. Angiotensin II type 1 receptor blockade: a new development in cardiovascular pharmacology.
    Leary AC; MacDonald TM
    Int J Clin Pract; 1998 Oct; 52(7):475-81. PubMed ID: 10622089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Angiotensin II antagonists: a promising pathway].
    Cohen-Solal A
    Arch Mal Coeur Vaiss; 2000 Jun; Spec No():10-1, 15. PubMed ID: 10949700
    [No Abstract]   [Full Text] [Related]  

  • 16. Manipulation of the renin angiotensin system in peripheral arterial disease.
    Hobbs SD; Thomas ME; Bradbury AW
    Eur J Vasc Endovasc Surg; 2004 Dec; 28(6):573-82. PubMed ID: 15531190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of angiotensin II and antagonists of the renin-angiotensin system on the cerebral circulation].
    Adzhienko LM
    Eksp Klin Farmakol; 2000; 63(4):74-9. PubMed ID: 11022315
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pathophysiological and clinical implications of AT(1) and AT(2) angiotensin II receptors in essential hypertension].
    Burnier M
    Drugs; 2002; 62 Spec No 1():21-9. PubMed ID: 12036386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anthology of the renin-angiotensin system: a one hundred reference approach to angiotensin II antagonists.
    Ménard J
    J Hypertens Suppl; 1993 Apr; 11(3):S3-11. PubMed ID: 8315517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists.
    Azizi M; Ménard J
    Circulation; 2004 Jun; 109(21):2492-9. PubMed ID: 15173039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.